Home » 論文ナビSCOPE » 研究機関分析 » 新潟県立がんセンター新潟病院の論文データ【研究動向まとめ】 新潟県立がんセンター新潟病院の論文データ【研究動向まとめ】 論文ナビは研究者によって運営される論文解説プラットフォームです。このページでは、最近二年間(2016-2017)で発表された文献データを独自に収集・集計して分かりやすくまとめました。論文キーワードマップ、代表的な研究機関、頻出キーワード、分野のシェア、分野関連図、関連文献等により、今までない情報を提供します。 統計データ non-small-cell lung cancer (NSCLC)gastric cancermelanomaJapanesenivolumabcolorectal cancerdocetaxellymph node metastasisnext-generation sequencingprognosisbreast cancermetastasischemotherapyJapanmultiple myelomabrain metastaseslymph node dissectionmetastatic breast cancersalivary duct carcinomaepidermal growth factor receptor (EGFR)HER2Japanese patientscervical cancersquamous cell carcinoma (SCC)PD-L1precision medicinesurvivaladjuvant chemotherapyHER2-negativeoverall survivalbevacizumabrandomized controlled trialmutationamrubicinchronic myeloid leukemia (CML)immunohistochemistrysegmentectomydexamethasoneearly gastric cancerclinical trialadverse eventssentinel lymph noderisk factorlobectomyadvanced gastric cancerelderlysurvival rateradiationsurgeryPD 1T cellslymphatic metastasisstomach neoplasmgastrectomydrug-induced lung injuryinterstitial lung diseasefulvestrantendocrine therapyNLRC-reactive protein (CRP)tumor-infiltrating lymphocyteEpstein-Barr virusendometrial cancerVEGF-Aadjuvantelderly patientsstem cell transplantationDNAadjuvant therapysplenectomycytologybiopsysmall cell lung cancer (SCLC)cisplatinflow cytometryfluorescence in situ hybridization (FISH)metastasectomyradiotherapyosteomyelitisrectal cancersafetypharmacokineticsp53androgen receptorStage Isurveillancesurgical site infectionsresectioncapecitabineimmune checkpoint inhibitorbiomarkerpembrolizumabimmunotherapyphase III studyanemiaesophageal cancercancer metastasispropensity score matchinglaparoscopic surgerylong-term outcomeAsianphase I studydose escalationprostate cancertiminglung cancer surgerywedge resectionthrombocytopeniatocilizumabglucocorticoidpredictionnomogramethnicityprogression-free survivalestrogen receptorinvasionLymphovascular invasiondistant metastasisangiographyliverT790Mcell-free DNAprospective studyquality-of-life (QOL)body weight lossendoscopic submucosal dissectiongemcitabinesarcomapredictive factorthymidine phosphorylasethymidylate synthaseirinotecanlymphadenectomytrastuzumabstereotactic radiotherapylung cancerextramammary Paget's diseaseoctogenarianbody mass indexquestionnaireesophageal squamous cell carcinomaamplificationpharmacodynamicsdasatinibrenal cell carcinoma (RCC)late recurrenceclinicopathological featuresnephrectomyneoadjuvantupper urinary tract urothelial carcinomaimatinibneoadjuvant chemotherapyAnti-PD-1 antibodypemetrexedcarboplatinmaintenanceKi 67aromatase inhibitorautophagy
